Mark Meerson
Impact in
- Aging top 10%
- Genetics, Aging, and Longevity in Model Organisms
-
- Telomeres, Telomerase, and Senescence
Papers in
-
- CRISPR and Genetic Engineering 2
-
- Telomeres, Telomerase, and Senescence 2
- Alzheimer's disease research and treatments 1
- Co-authors
- Maxim V. Gerashchenko (1 shared paper)Vadim N. Gladyshev (1 shared paper)Ivan V. Kulakovskiy (1 shared paper)Sergey E. Dmitriev (1 shared paper)Aleksandra S. Anisimova (1 shared paper)Maria P. Rubtsova (2 shared papers)О. А. Донцова (2 shared papers)Alexey V. Beletsky (1 shared paper)
- Journals
- Scientific Reports (1 paper)Nucleic Acids Research (1 paper)Proceedings of the National Academy of Sciences (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)Blood (1 paper)
- Partner nations
- RussiaUnited States
In The Last Decade
Mark Meerson
4 papers receiving 157 citations
Peers
Comparison fields: 5 of 47
- Aging 21
- Physiology 48
- Molecular Biology 121
- Cancer Research 19
- Cell Biology 12
Countries citing papers authored by Mark Meerson
This map shows the geographic impact of Mark Meerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Meerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Meerson more than expected).
Fields of papers citing papers by Mark Meerson
This network shows the impact of papers produced by Mark Meerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Meerson. The network helps show where Mark Meerson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Meerson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 80 | |
| 2 | 2018 | 37 | |
| 3 | 2019 | 36 | |
| 4 | 2021 | 7 | |
| 5 | 2022 | 0 |
About Mark Meerson
Mark Meerson is a scholar working on Molecular Biology, Physiology, Pharmacology, Pathology and Forensic Medicine and Computational Theory and Mathematics, having authored 5 papers that have together received 160 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (2 papers), Telomeres, Telomerase, and Senescence (2 papers), Animal Genetics and Reproduction (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper), Alzheimer's disease research and treatments (1 paper), Cancer-related molecular mechanisms research (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Aging (21 citations), Physiology (48 citations), Molecular Biology (121 citations), Cancer Research (19 citations) and Cell Biology (12 citations). Mark Meerson has collaborated with scholars based in Russia and United States. Frequent co-authors include Maxim V. Gerashchenko, Vadim N. Gladyshev, Ivan V. Kulakovskiy, Sergey E. Dmitriev, Aleksandra S. Anisimova, Maria P. Rubtsova, О. А. Донцова, Alexey V. Beletsky, Timofei S. Zatsepin and Nikolai V. Ravin. Their work appears in journals such as Scientific Reports, Nucleic Acids Research, Proceedings of the National Academy of Sciences, CPT Pharmacometrics & Systems Pharmacology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.